Table 2 Laboratory examination and CT radiographic characteristics
From: A single-center, retrospective study of COVID-19 features in children: a descriptive investigation
Characteristics | Group A | Group B | Group A + B | Group C |
|---|---|---|---|---|
Laboratory examinationa | ||||
Hemoglobin count increase (↑) | 2/43 (5%) | 2/7 (29%) | 4/50 (8%) | 6/26 (23%) |
Hemoglobin count normal | 36/43 (83%) | 4/7 (57%) | 40/50 (80%) | 18/26 (69%) |
Hemoglobin count decrease (↓) | 5/43 (12%) | 1/7 (14%) | 6/50 (12%) | 2/26 (8%) |
C-reactive protein level increase (↑) | 10/43 (23%) | 0/7 (0%) | 10/50 (20%) | 8/26 (31%) |
C-reactive protein level normal | 33/43 (77%) | 7/7 (100%) | 40/50 (80%) | 18/26 (69%) |
Platelet count increase (↑) | 1/43 (2%) | 1/7 (14%) | 2/50 (4%) | 1/26 (4%) |
Platelet count normal | 35/43 (82%) | 6/7 (86%) | 41/50 (82%) | 18/26 (69%) |
Platelet count decrease (↓) | 7/43 (16%) | 0/7 (0%) | 7/50 (14%) | 7/26 (27%) |
Lymphocyte count increase (↑) | 2/43 (5%) | 2/7 (29%) | 4/50 (8%) | 2/26 (8%) |
Lymphocyte count normal | 34/43(79%) | 4/7 (57%) | 38/50 (76%) | 18/26 (69%) |
Lymphocyte count decrease (↓) | 7/43 (16%) | 1/7 (14%) | 8/50 (16%) | 6/26 (23%) |
Blood leukocyte count increase (↑) | 2/43 (5%) | 0/7 (0%) | 2/50 (4%) | 1/26 (4%) |
Blood leukocyte count normal | 23/43 (53%) | 6/7 (86%) | 29/50 (58%) | 13/26 (50%) |
Blood leukocyte count decrease (↓) | 18/43 (42%) | 1/7 (14%) | 19/50 (38%) | 12/26 (46%) |
CT radiographic characteristics | ||||
Overall patients with CT abnormalities | 43/43 (100%) | 0/7 (0%) | 43/50 (86%) | 26/26 (100%) |
Ground-glass opacity | 29/43 (67%) | 0/7 (0%) | 29/50 (58%) | 21/26 (81%) |
Local patchy shadowing | 16/43 (37%) | 0/7 (0%) | 16/50 (32%) | 7/26 (27%) |
Bilateral patchy shadowing | 9/43 (21%) | 0/7 (0%) | 9/50 (18%) | 5/26 (19%) |
Interstitial abnormalities | 3/43 (7%) | 0/7 (0%) | 3/50 (6%) | 0/26 (0%) |
Pleural fluid | 1/43 (2%) | 0/7 (0%) | 1/50 (2%) | 0/26 (0%) |
Lymphadenopathy | 0/43 (0%) | 0/7 (0%) | 0/50 (0%) | 0/26 (0%) |
Lesion characteristics and locationb | ||||
Subpleural | 41/43 (95%) | 0/7 (0%) | 41/50 (82%) | 21/26 (81%) |
Parallel to the pleura | 21/43 (49%) | 0/7 (0%) | 21/50 (42%) | 10/26 (38%) |
Vascular thickening shadowing | 10/43 (23%) | 0/7 (0%) | 10/50 (20%) | 10/26 (38%) |
Upper lobe of the lung | 22/43 (51%) | 0/7 (0%) | 22/50 (44%) | 14/26 (54%) |
Middle lobe of the lung | 9/43 (21%) | 0/7 (0%) | 9/50 (18%) | 6/26 (23%) |
Lower lobe of the lung | 28/43 (65%) | 0/7 (0%) | 28/50 (56%) | 19/26 (73%) |
Posterior segment of lower lung lobes | 22/43 (51%) | 0/7 (0%) | 22/50 (44%) | 12/26 (46%) |